+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Pharmacogenomics"

Genetic Testing Market Overview, 2025-2030 - Product Thumbnail Image

Genetic Testing Market Overview, 2025-2030

  • Report
  • November 2025
  • 109 Pages
  • Global
From
From
From
From
Genomics Market Overview, 2025-30 - Product Thumbnail Image

Genomics Market Overview, 2025-30

  • Report
  • June 2025
  • 106 Pages
  • Global
From
Genomics Market Outlook, 2030 - Product Thumbnail Image

Genomics Market Outlook, 2030

  • Report
  • June 2025
  • 194 Pages
  • Global
From
From
From
From
From
From
From
From
From
Middle East and Africa Genetic Testing Market Outlook, 2030 - Product Thumbnail Image

Middle East and Africa Genetic Testing Market Outlook, 2030

  • Report
  • November 2025
  • 70 Pages
  • Africa, Middle East
From
Asia-Pacific Genetic Testing Market Outlook, 2030 - Product Thumbnail Image

Asia-Pacific Genetic Testing Market Outlook, 2030

  • Report
  • November 2025
  • 97 Pages
  • Asia Pacific
From
Europe Genetic Testing Market Outlook, 2030 - Product Thumbnail Image

Europe Genetic Testing Market Outlook, 2030

  • Report
  • November 2025
  • 100 Pages
  • Europe
From
Loading Indicator

Pharmacogenomics is a field of genomics that studies the relationship between an individual's genetic makeup and their response to drugs. It is used to develop personalized medicine, which is tailored to an individual's genetic profile. This field of genomics has the potential to revolutionize the way drugs are developed and prescribed, as it can help to identify which drugs are most effective for a particular patient. It can also help to reduce the risk of adverse drug reactions, as well as reduce the cost of drug development. Pharmacogenomics is a rapidly growing field, with many companies investing in research and development. Examples of companies in the market include 23andMe, Genomics England, and Illumina. Show Less Read more